Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease Not Responding Adequately to Current Therapy

NCT05049525 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT05049525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease Not Responding Adequately to Current Therapy
Lead sponsor
Montreal Heart Institute
Phase
Phase 2
Overall status
Terminated
Start date
February 22, 2022
Completion date
February 28, 2024
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel diseases